Pharmacological and X-ray Structural Characterization of a Novel Selective Androgen Receptor Modulator: Potent Hyperanabolic Stimulation of Skeletal Muscle with Hypostimulation of Prostate in Rats.
From: Department of Metabolic Diseases, Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, NJ 08543, USA.
Endocrinology
- Publish Date: Jan 2007
- ISSN: 0013-7227
- Volume: 148
- Issue: 1
- Pages: 4-12
- Medium: Print
- Language: English
- Citation (JAMA): Ostrowski Jacek, Kuhns Joyce E, Lupisella John A, et al. Pharmacological and X-ray Structural Characterization of a Novel Selective Androgen Receptor Modulator: Potent Hyperanabolic Stimulation of Skeletal Muscle with Hypostimulation of Prostate in Rats.. Endocrinology Jan 2007;148:4-12
Abstract
A novel, highly potent, orally active, nonsteroidal tissue selective androgen receptor (AR) modulator (BMS-564929) has been identified, and this compound has been advanced to clinical trials for the treatment of age-related functional decline. BMS-564929 is a subnanomolar AR agonist in vitro, is highly selective for the AR vs. other steroid hormone receptors, and exhibits no significant interactions with SHBG or aromatase. Dose response studies in castrated male rats show that BMS-564929 is substantially more potent than testosterone (T) in stimulating the growth of the levator ani muscle, and unlike T, highly selective for muscle vs. prostate. Key differences in the binding interactions of BMS-564929 with the AR relative to the native hormones were revealed through x-ray crystallography, including several unique contacts located in specific helices of the ligand binding domain important for coregulatory protein recruitment. Results from additional pharmacological studies effectively exclude alternative mechanistic contributions to the observed tissue selectivity of this unique, orally active androgen. Because concerns regarding the potential hyperstimulatory effects on prostate and an inconvenient route of administration are major drawbacks that limit the clinical use of T, the potent oral activity and tissue selectivity exhibited by BMS-564929 are expected to yield a clinical profile that provides the demonstrated beneficial effects of T in muscle and other tissues with a more favorable safety window.
Mesh Headings (Keywords): Aging, Animals, Aromatase, Binding, Competitive, Cell Division, Cell Line, Tumor, Crystallography, X-Ray, Dihydrotestosterone, Epithelial Cells, Humans, Imidazoles, Ligands, Luteinizing Hormone, Male, Muscle, Skeletal, Orchiectomy, Prostate, Protein Structure, Tertiary, Pyrroles, Rats, Rats, Sprague-Dawley, Receptors, Androgen, Testosterone, Transcription, Genetic
Check for Full Text / PubMed Unique Identifier (PMID): 17008401
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.